Maiwald Magazine

Maiwald Blog

9 Dec 2025 - Maiwald Blog

New fee schedule for the Unified Patent Court (UPC) from 1 January 2026

The Administrative Committee of the UPC has decided on a comprehensive reform of court fees, which will come into force on 1 January 2026. The adjustment affects almost all fe...

4 Nov 2025 - Maiwald Blog

Why Patent Defense and Military Technologies?

When developing high-tech technologies for use in defense and military applications, you might wonder whether patent protection is necessary. Even though your customer base is...

26 May 2025 - Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

The Board of Appeal of the EPO has issued two decisions concerning appeal cases T 0123/22 and T 1191/22, which relate to the interpretation of Rule 80 EPC. The fundamental que...

All articles

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Maiwald in the press

Staff News

All Staff News

Publications

All publications

Awards

20 Nov 2025 - Award

IAM Strategy 300 Global Leaders 2026

We are delighted that IAM has recognised seven of our partners as Strategy 300 Global Leaders—some again, others for the first time:

31 Oct 2025 - Award

JUVE Patent Rankings Germany 2025

JUVE Patent has published the latest JUVE Patent Germany Ranking 2025. Our firm is once again recommended in the categories “Patent Filing�...

1 Oct 2025 - Award

Managing IP’s Rising Stars 2025

Managing IP has revealed this year’s Rising Stars in IP list, a special publication which recognises some of the best up-and-coming IP practitioners in private practice. We ...

All awards

Events

Thu.

5 Mar 2026 |Upcoming

Maiwald invites you to the MAItalk in Munich

On March 5 2026, we warmly invite you to the MAItalk seminar at our Munich office. Look forward to engaging, practice‑oriented presentations and stimulating discussions in a collegial atmosphere - ideal for exchanging ideas with experts and peers. Catering will be provided throughout the event.

Tue.

10 Mar 2026 |Upcoming

2nd European Summit for Women Leaders in Life Science Law

Maiwald will once again participate in the “European Summit for Women Leaders in Life Sciences Law” in Brussels in 2026 and is looking forward to engaging with international experts from across the life sciences legal community. The conference offers practical insights into current legal and regulatory developments i...

Wed.

8 Apr 2026 |Upcoming

Maiwald at the 33rd Annual IP Conference of the Fordham IP Institute in New York

The 33rd Annual IP Law & Policy Conference of the renowned Fordham Intellectual Property Institute will take place from 8 to 10 April 2026 at Fordham Law School in New York. This event brings together leaders from government, the judiciary, academia and business worldwide to discuss current challenges in intellectual property.

Mon.

19 Jan 2026 |Past Event

5th Pharma & Biotech Patent Litigation Conference, Amsterdam

The „Pharma & Biotech Patent Litigation Summit Europe 2026“ is a key industry meeting point for experts in pharmaceutical and biotech patent litigation in Europe. It focuses on current developments at the UPC, recent case law, SPC issues, and strategic questions around cross‑border enforcement of patents in the life sciences sector.

All events

News and Releases